Insider filing · KNSA
John F. Paolini
CHIEF MEDICAL OFFICER
profile →
Kiniksa Pharmaceuticals International, plc
KNSA · Healthcare · 72 filings in 24 months
ticker →
John F. Paolini sold $955K of Kiniksa Pharmaceuticals International (KNSA)
Executed Aug 6 2025, disclosed Aug 8 2025, 2 days later.
Value, as filed
$955K
29,325 sh × $32.55
Executed
Aug 6 2025
the trade date, as filed
Disclosed
Aug 8 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JPJohn F. Paolini (CHIEF MEDICAL OFFICER) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $8.8M of KNSA (94,397 sh across 8 lots, as filed), executed Oct 30.
The name
KNSAHealthcare · Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by John F. Paolini in KNSA
KNSASALE
Kiniksa Pharmaceuticals International, plc
$8.8M94,397 sh across 8 lots
Exec Oct 30
Filed Nov 3 · 6:28 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $3.1M
58,424 sh across 2 lots
Exec May 1
Filed May 5 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $1.8M
40,000 sh across 3 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc $3.1M
82,542 sh × $37.14
Exec Oct 31 2025
Filed Nov 4 2025 · 5:30 PM ET